ProfoundBio US Co.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
ProfoundBio US Co. - overview
Established
2018
Location
Woodinville, WA, US
Primary Industry
Biotechnology
About
Founded in 2018 and based in Washington, US, ProfoundBio US Co. , operates as a medical company for oncology biotherapeutics firms that are developing innovative antibody-based medicines with the potential to cure cancer patients. In May 2024, Genmab A/S acquired ProfoundBio US Co. from Ally Bridge Group, Chang'an Capital, Gaorong Ventures, Janus Henderson Investors, K2VC, LifeSci Venture Partners, Lilly Asia Ventures, Logos Capital, LYFE Capital, Medicxi Ventures, Octagon Capital, OrbiMed Advisors, Oriza Holdings, Piper Heartland Healthcare Capital, Sequoia Capital Global Equities, Sierra Technologies, Inc.
, Surveyor Capital, and T. Rowe Price, for USD 1. 8 billion. The company's product pipeline primarily consists of antibody-coupled drugs (ADCs) and other antibody-based therapeutic programs.
In addition, it develops novel targeted drugs including PRO1184, an ADC drug targeting folate receptor alpha (FRα), and PRO1160, an ADC drug covering hematologic and solid tumor indications targeting CD70.
Current Investors
Chang'an Capital, Gaorong Ventures, K2VC
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Oncology/Cancer Treatment
Verticals
HealthTech
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.